Browse studies

Find your next paid study

6 recruiting studies matching your filters

Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance

The purpose of this research is to determine whether bladder cancer monitoring can be improved by replacing some cystoscopy procedures with urine testing. Spec…

Non-muscle-invasive Bladder Cancer

Estimated

~$10 – $5,625

White River Junction Veterans Affairs Medical CenterNCT05796375

Phase 2

A Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Ri…

High-Risk Non-Muscle-Invasive Bladder Cancer

Estimated

~$10 – $8,750

CG Oncology, Inc.NCT06567743

Predicting Outcomes in Intermediate and High-risk Non-muscle Invasive Bladder Cancer Using Automated Analysis of Digital Pathology Data

This is a multi-center study and the aim is to develop and validate an Artificial Intelligence (AI) -based histologic analysis tool to predict responsiveness t…

Non-muscle-invasive Bladder Cancer

Estimated

~$10 – $750

University of Texas Southwestern Medical CenterNCT05825950

Phase 1

A Phase I Trial of Cancer-targeting Micelles for Non-myoinvasive Bladder Cancer

This clinical trial is to determine the safety and effectiveness of an investigational bladder cancer drug named "PLZ4-coated paclitaxel-loaded nanoscale micel…

Non-muscle-invasive Bladder Cancer

Estimated

~$10 – $5,625

VA Office of Research and DevelopmentNCT05519241

Phase 1

A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer

This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety an…

Non-muscle-invasive Bladder Cancer

Estimated

~$10 – $8,750

SURGE TherapeuticsNCT05710848

Observational

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

The PRIMER (Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy) trial is a pilot designed to estimate the feasibility of…

Bladder CancerNon-muscle-invasive Bladder CancerMuscle-Invasive Bladder Carcinoma

Estimated

~$10 – $6,250

University of VirginiaNCT05790850